STING1 and neoplasm: Previous studies have confirmed that GPR162 can promote STING-related pathway-dependent DNA damage responses, thus we want to see if the GPR162-STING-DNA damage axis can be employed as a transformation strategy to boost the anti-tumor effect of radiation.